Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
PaperCitations, authors & open-access status
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,538 citations, 2005 year and gold oa status.
3,538
Citations
2005
Year
gold
OA Status